SG/PUT/NOVO-NORDISK B/750/0.1/20.12.24 Stock

DE000SU52388

Market Closed - Boerse Frankfurt Warrants 03:37:34 2024-07-05 pm EDT
0.27 ^EUR	-3.57%

Current month	+17.39%
1 month	-6.90%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart NOVO NORDISK A/S

Chart SG/PUT/NOVO-NORDISK B/750/0.1/20.12.24

Latest news about NOVO NORDISK A/S

Novo Nordisk Reprimanded in UK Over Undisclosed Payments; Novartis, Pfizer Found in Breach of Industry Code	Jul. 05	MT
UK Pharmaceutical Trade Group Slams Novartis, Three Others for Breaches	Jul. 05	MT
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading	Jul. 05	MT
Novo Nordisk reprimanded in UK for failure to disclose payments to healthcare sector	Jul. 05	RE

More news

Quotes 5-day view

Date	Price	Change
24-07-05	0.27	-3.57%
24-07-04	0.28	0.00%
24-07-03	0.28	+16.67%
24-07-02	0.24	+14.29%
24-07-01	0.21	-8.70%

Real-time Boerse Frankfurt Warrants

Last update July 05, 2024 at 03:37 pm EDT

More quotes

Static data

Product type	Warrants
Buy / Sell	PUT
Underlying	NOVO NORDISK A/S
Issuer	Société Générale
WKN	SU5238
ISIN	DE000SU52388
Date issued	2023-12-20
Strike	750 kr
Maturity	2024-12-20 (168 Days)
Parity	10 : 1
Emission price	1.78 €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	1.74 €
Lowest since issue	0.18 €
Delta	0x
Omega	0.000000
Premium	0x
Gearing	47.44x
Moneyness	0.7700
Difference Strike	-224 kr
Difference Strike %	-29.87%
Spread	0.01 €
Spread %	3.57%
Intrinsic value	0.000000
Present value	0.2850

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).

Sector

More about the company